New and Generic Drug Approvals
Featured In: Regulatory News
By Federal Drug Administration
Tuesday, March 9, 2010
New and Generic Drug Approvals
Visit Drugs@FDA to search Drug Approval Reports by Month.
March 9, 2010
- Betaxon (levobetaxolol hydrochloride) Ophthalmic Suspension, Alcon Research, Ltd., Labeling Revision
- ChloraPrep One-Step (chlorhexidine gluconate and isopropyl alcohol) Sponge, Enturia Inc., Labeling Revision
- ChloraPrep One-Step Frepp (chlorhexidine gluconate and isopropyl alcohol) Sponge, Enturia Inc., Labeling Revision
- ChloraPrep One-Step with Tint (chlorhexidine gluconate and isopropyl alcohol) Sponge, Enturia Inc., Labeling Revision
- Copegus (ribavirin) Tablets, Hoffmann-La Roche Inc., Labeling Revision
- Inderide-40/25 (hydrochlorothiazide and propranolol hydrochloride) Tablets, Akrimax Pharmaceuticals, LLC, Labeling Revision
- Inderide-80/25 (hydrochlorothiazide and propranolol hydrochloride) Tablets, Akrimax Pharmaceuticals, LLC, Labeling Revision
- Nexium (esomeprazole magnesium) Delayed-Released Oral Solution, AstraZeneca, Labeling Revision
- Nexium (esomeprazole magnesium) Delayed-Release Capsules, AstraZeneca, Labeling Revision
- Nexium (esomeprazole magnesium) Delayed-Release Oral Solution, AstraZeneca, Labeling Revision
- Nexium IV (esomeprazole sodium) Intravenous Injection, AstraZeneca, Labeling Revision
- Tyzeka (telbivudine) Tablets, Novartis Pharmaceuticals Corp., Labeling Revision
- Tyzeka (telbivudine) Oral Solution, Novartis Pharmaceuticals Corp., Labeling Revision
- Vanos (fluocinonide) Topical Cream, Medicis Pharmaceutical Corp., Labeling Revision
March 5, 2010
- Adalat (nifedipine) Extended-Release Tablets, Bayer HealthCare, Labeling Revision
- Avelox (moxifloxacin hydrochloride) Tablets, Bayer HealthCare Pharmaceuticals, Inc., Labeling Revision
- Avelox in Sodium Chloride 0.8% in Plastic Container (moxifloxacin hydrochloride) I.V. Injection, Bayer HealthCare Pharmaceuticals, Inc., Labeling Revision
- ChloraPrep One-Step Sepp (chlorhexidine gluconate and isopropyl alcohol) Topical Swab, CareFusion, LLC, Labeling Revision
- Femara (letrozole) Tablets, Novartis Pharmaceuticals Corporation, Efficacy Supplement with Clinical Data to Support
- Fluvastatin Capsules, Teva Pharmaceuticals, Tentative Approval
- Invega (paliperidone) Extended-Release Tablets, Johnson & Johnson Pharmaceutical, Labeling Revision
- Levetiracetam Oral Solution, Wockhardt, Approval
- Rapaflo (silodosin) Capsules, Watson Laboratories, Inc., Labeling Revision
- Xifaxan (rifaximin) Tablets, Salix Pharmaceuticals, Inc., Labeling Revision
- Zocor (simvastatin) Tablets, Merck & Co., Inc., Labeling Revision
March 3, 2010
- Exalgo (hydromorphone hrdrochloride) Extended-Release Tablets, ALZA Corporation, Approval
- Fosamax (alendronate sodium) Tablets, Merck & Co., Inc., Labeling Revision
- Fosamax (alendronate sodium) Oral Solution, Merck & Co., Inc., Labeling Revision
- Fosamax Plus D (alendronate sodium and cholecalciferol) Tablets, Merck & Co., Inc., Labeling Revision
- Norditropin (somatropin [rDNA origin]) Injection, Novo Nordisk Inc., Manufacturing Change or Addition
- Tamsulosin Hydrochloride Capsules, IMPAX Laboratories, Inc., Approval
- Temozolomide Capsules, Barr Laboratories, Inc., Approval
March 2, 2010
- Articaine Hydrochloride and Epinephrine Injection, TechReg Services, Inc., Approval
- Cefoxitin Injection, West-Ward Pharmaceutical Corp., Approval
- Hydralazine Hydrochloride Tablets, Zydus Pharmaceuticals USA, Approval
- Janumet (metformin hydrochloride and sitagliptin phosphate) Tablets, Merck, Efficacy Supplement with Clinical Data to Support
- Januvia (sitagliptin phosphate) Tablets, Merck Co. Inc., Efficacy Supplement with Clinical Data to Support
- Wellbutrin (bupropion hydrochloride) Tablets, GlaxoSmithKline, Labeling Revision
- Wellbutrin (bupropion hydrochloride) Tablets, GlaxoSmithKline, Labeling Revision
- Wellbutrin XL (bupropion hydrochloride) Extended-Release Tablets, Biovail Technologies, Ltd., Labeling Revision
- Vpriv (velaglucerase alfa) Injection, Shire Human Genetic Therapies, Inc., Approval
- Zyban (bupropion hydrochloride) Extended-Release Tablets, GlaxoSmithKline, Labeling Revision
- Zyrtec Allergy (cetirizine hydrochloride) Tablets, McNeil Consumer Healthcare, Labeling Revision
March 1, 2010
- Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended-Release Tablets, Sandoz Inc., Tentative Approval
- Glumetza (metformin hydrchloride) Extended-Release Tablets, DepoMed, Inc., Labeling Revision
- Hydrocodone Bitartrate and Acetaminophen Oral Solution, Mikart Inc., Approval
- Lax-Lyte with Flavor Packs (Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate and Potassium Chloride) Oral Solution, Paddock Laboratories, Inc., Approval
- Rocephin (ceftriaxone sodium) Intramuscular I.V. Injection, Hoffmann-La Roche, Inc., Labeling Revision
- Ropinirole Hydrochloride Tablets, Glenmark Generics Ltd., Approval
- Treanda (bendamustine hydrochloride) I.V. Powder, Cephalon Inc., Labeling Revision
February 25, 2010
- Bystolic (nebivolol hydrochloride) Tablets, Forest Laboratories, Inc., Efficacy Supplement
- Cayston (aztreonam) Inhalation Solution, Gilead Sciences, Inc., Approval
- Cefoxitin and Dextrose in Duplex Container Injection, B. Braun Medical, Inc., Labeling Revision
- Cyanokit (hydroxocobalamin) Injection, Merck Sante s.a.s., Labeling Revision
- Dyazide (hydrochlorothiazide and triamterene) Capsules, GlaxoSmithKline, Labeling Revision
- Finasteride Tablets, Accord Healthcare, Inc., Approval
- Forane (isoflurane) Inhalation Liquid, Baxter Healthcare Corporation, Labeling Revision
- Imiquimod Cream, Nycomed, Inc., Approval
- Intelence (etravirine) Tablets, Tibotec, Inc., Labeling Revision
- Marcaine (bupivacaine hydrochloride) Injection, Hospira, Inc., Labeling Revision
- Marcaine (bupivacaine hydrochloride) Injection, Hospira, Inc., Labeling Revision
- Naratriptan Tablets, Roxane Laboratories, Inc., Tentative Approval
- Niaspan (niacin) Extended-Release Tablets, Abbott Laboratories, Labeling Revision
- Norethindrone and Ethinyl Estradiol Tablets, Watson Laboratories, Inc., Approval
- Polyethylene Glycol 3350 and Electrolytes Oral Solution, Paddock Laboratories, Approval
- Rocaltrol (calcitriol) Capsules, Validus Pharmaceuticals, Labeling Revision
- Septocaine (articaine hydrochloride and epinephrine) Injection, Deproco, Inc., Labeling Revision
- Tamiflu (oseltamivir phosphate) Capsules, Hoffmann-La Roche, Inc., Labeling Revision and Efficacy Supplement
- Tamiflu (oseltamivir phosphate) Oral Suspension, Hoffmann-La Roche, Inc., Labeling Revision and Efficacy Supplement
- Tracleer (bosentan) Tablets, Actelion, Ltd., Labeling
February 24, 2010
- Carbocaine (mepivacaine hydrochloride) Injection, Hospira, Inc., Labeling Revision
- Desloratadine Tablets, Orchid Healthcare, Approval
- Mirapex ER (pramipexole dihydrochloride) Extended-Release Tablets, Boehringer Ingelheim Pharmaceuticals, Inc., Approval
- Naropin (ropivacaine hydrochloride monohydrate) Injection, APP Pharmaceuticals, Labeling Revision
- Nesacaine (chloroprocaine hydrochloride) Injection, APP Pharmaceuticals, Labeling Revision
- Xylocaine (lidocaine hydrochloride) Injection, APP Pharmaceuticals, Labeling Revision
- Xylocaine 4% Preservative Free (lidocaine hydrochloride) Injection, APP Pharmaceuticals, Labeling Revision
February 23, 2010
- Alendronate Sodium Tablets, Cadista Pharmaceuticals Inc., Approval
- Baclofen Tablets, Matrix Laboratories Ltd., Approval
- Caduet (amlodipine besylate and atorvastatin calcium) Tablets, Pfizer, Inc., Labeling Revision
- Ciclopirox Topical Solution, VersaPharm Inc., Approval
- Coartem (artemether and lumefantrine) Tablets, Novartis Pharmaceuticals Corp., Labeling Revision
- Donepezil Hydrochloride Tablets, Torrent Pharmaceuticals Ltd., Tentative Approval
- Metformin Hydrochloride Extended-Release Tablets, Torrent Pharmaceuticals Ltd., Approval
SOURCE